An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
Clinical trial NCT05653986 · COMPLETED
Trial details
- NCT number
- NCT05653986
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-18
- Primary completion
- 2024-08-05
- Enrollment
- 391
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.